Moderate Alcohol Consumption May Cut Fasting Insulin, HbA1c

This article originally appeared here.
Share this content:
Moderate Alcohol Consumption May Cut Fasting Insulin, HbA1c
Moderate Alcohol Consumption May Cut Fasting Insulin, HbA1c

(HealthDay News) -- Among individuals without diabetes, moderate alcohol consumption may decrease fasting insulin and hemoglobin A1c (HbA1c) concentrations, according to a review and meta-analysis published in the April issue of Diabetes Care.

Ilse C. Schrieks, from the Netherlands Organization of Applied Scientific Research in Zeist, and colleagues conducted a systematic review and meta-analysis of intervention studies to examine the effect of alcohol consumption on insulin sensitivity and glycemic status. Data were included from 14 intervention studies in a meta-analysis of six glycemic end points.

The researchers found that, compared with the control condition, alcohol consumption did not influence estimated insulin sensitivity (standardized mean difference [SMD], 0.08) or fasting glucose (SMD, 0.07), but was correlated with reductions in HbA1c (SMD, −0.62) and fasting insulin concentrations (SMD, −0.19). Among women, but not men, alcohol consumption correlated with reduced fasting insulin (SMD, −0.23) and tended to improve insulin sensitivity (SMD, 0.16). After excluding studies with high alcohol dosages (>40 g/day), results were similar. Dosage and duration of the intervention did not influence results.

"These results may partly explain the lower risk of type 2 diabetes with moderate alcohol consumption found in observational studies," the authors write. "However, more intervention studies with a longer intervention period are necessary to confirm the results."

Two of the authors were partially supported by the Dutch Foundation for Alcohol Research, representing Dutch producers of and traders in beer, wine, and spirits.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »